Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Xenon Pharmaceuticals Inc. (XENE)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -47.5-41.7-37.4-37.2-31.2-19.7-25.6-15.4
Depreciation and amortization  0.60.40.50.40.40.40.30.2
Stock-based compensation     -8.8   -4.7
Deferred taxes     -0.2   0.0
Change in working capital   [+]5.6-0.636.81.45.8-5.825.1-0.3
Other operating activities  8.17.6-32.614.08.16.7-20.55.2
Cash from operations  -33.2-34.4-32.7-30.4-16.9-18.4-20.7-15.0
   
Capital expenditures  2.12.21.81.90.50.20.52.8
Purchases of short-term investments, net  162.3108.3114.7483.272.769.0257.2177.9
Other cash from investing  -136.5-63.9-130.8-719.2-71.9-118.1-473.1-165.2
Cash from investing  27.946.6-14.3-234.11.3-48.9-215.415.6
   
Repurchase of common stock, net      -7.97.9  
Option exercises    0.00.7  0.00.0
Other cash from financing    0.01.4277.8 324.04.8
Cash from financing  0.00.00.00.7269.97.9324.04.8
   
Free cash flow  -31.1-32.2-31.0-28.5-16.3-18.2-20.2-12.2
        Per share (diluted)  ($0.47)($0.49)($0.51)($0.44)($0.29)($0.33)($0.46)($0.29)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy